Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells

Detalles Bibliográficos
Autores principales: Thijssen, Rachel, Alvarez-Diaz, Silvia, Grace, Clea, Gao, Ming-yuan, Segal, David H., Xu, Zhen, Strasser, Andreas, Huang, David C. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370228/
https://www.ncbi.nlm.nih.gov/pubmed/32555451
http://dx.doi.org/10.1038/s41418-020-0576-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370228/
https://www.ncbi.nlm.nih.gov/pubmed/32555451
http://dx.doi.org/10.1038/s41418-020-0576-2

Ejemplares similares